David M. Kendall, Chief Medical Officer at MANNKIND CORP (MNKD), bought 2,304 shares at $0.95 ($2K) on 2020-01-31, disclosed to the SEC on 2020-02-03.
Open-market purchase of $2k MNKD by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| MNKD | BUY | 2019-01-31 | $5K | — | Filing → |